Shopping Cart
- Remove All
- Your shopping cart is currently empty
KPT185 (KPT 185) is a selective CRM1 inhibitor, inducing apoptosis, cell-cycle arrest.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $30 | In Stock |
Description | KPT185 (KPT 185) is a selective CRM1 inhibitor, inducing apoptosis, cell-cycle arrest. |
Targets&IC50 | CRM1:100-500nM |
In vivo | In leukemia cells (IC50=100 nM-500 nM), KPT-185 significantly inhibited cell proliferation. In AML cell lines and primary AML mother cells, KPT-185 was able to arrest the cell cycle and induce apoptosis. In pancreatic cancer cells, KPT-185 inhibited cell proliferation and induced apoptosis, but KPT-185 did not affect the growth of human pancreatic ductal epithelial cells. |
Cell Research | Cells are seeded into 96-well plates and treated for 24, 48, and 72 hours with KPT-SINE at various concentrations ranging from 10 nM to 10 μM. Cell viability is evaluated using the cell proliferation reagent WST-1 according to the manufacturer's protocol. The absorbance of wells at 450 nm (reference wavelength, 650 nm) is measured with a microplate reader. (Only for Reference) |
Alias | KPT-185, KPT 185 |
Molecular Weight | 355.31 |
Formula | C16H16F3N3O3 |
Cas No. | 1333151-73-7 |
Smiles | COc1cc(cc(c1)C(F)(F)F)-c1ncn(C=CC(=O)OC(C)C)n1 |
Relative Density. | 1.29 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
Solubility Information | H2O: <1 mg/mL DMSO: 66 mg/mL (185.8 mM) Ethanol: 66 mg/mL (185.8 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO/Ethanol
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.